Dominic Oliver

I am a Senior Researcher working with Professor Philip McGuire. My interests lie in prevention of psychosis and other severe mental disorders, particularly in combining prediction modelling methods, artificial intelligence and routinely collected healthcare data to improve identification of individuals at risk, predict their clinical outcomes and their response to interventions. 

I lead the Wellcome Trust-funded ARIADNE (ARtificial Intelligence-based Assessment to Detect iNdividuals with Emerging psychosis risk) programme, which aims to transform the detection of individuals at clinical high risk for psychosis. This work aims to develop and validate a novel voice-based assessment platform powered by generative artificial intelligence that can conduct naturalistic clinical interviews to identify psychosis risk. 

I also lead biomarker acquisition and analysis within the Stratification and Treatment in Early Psychosis (STEP) programme, an international series of multicentre clinical trials investigating cannabidiol (CBD) across different stages of psychosis, including clinical high risk for psychosis, first-episode psychosis, and treatment-resistant psychosis.

I completed my PhD in 2022 ("Improving prediction of psychosis risk") at the Institute of Psychiatry, Psychology & Neuroscience, King's College London, under the supervision of Professor Paolo Fusar-Poli and Professor Philip McGuire. Alongside my work at the University of Oxford, I maintain active collaborations with colleagues at King’s College London and other international research centres, with the aim of advancing precision approaches to the prediction and prevention of severe mental illness.